Jpmorgan Chase & Co »

Supernus Pharmaceuticals shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.5M 156k 28.94
2023-09-30 $3.7M 134k 27.57
2023-06-30 $4.3M 142k 30.06
2023-03-31 $6.5M 147k 44.07
2022-12-31 $8.7M 243k 35.66
2022-06-30 $7.3M 253k 28.92
2022-03-31 $2.3M 71k 32.31
2021-12-31 $0 60k 0.00
2021-03-31 $1.3M 49k 26.18
2020-12-31 $1.8M 70k 25.16
2020-09-30 $792k 38k 20.84
2020-06-30 $1.0M 44k 23.35
2020-03-31 $669k 37k 17.98
2019-12-31 $946k 40k 23.73
2019-09-30 $511k 19k 27.46
2019-06-30 $522k 16k 31.85
2019-03-31 $495k 14k 35.29
2018-12-31 $1.7M 52k 33.22
2018-09-30 $7.2M 143k 50.35
2018-06-30 $12M 199k 59.85
2018-03-31 $21M 462k 45.76
2017-12-31 $7.1M 174k 41.18
2017-06-30 $2.3M 52k 44.12
2017-03-31 $2.3M 77k 29.41
2016-12-31 $2.8M 94k 29.41
2016-09-30 $654k 27k 24.71
2016-06-30 $2.0k 85 23.53
2016-03-31 $2.9M 188k 15.25
2015-12-31 $2.5M 188k 13.44